NORTHERN TRUST CORP - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 55 filers reported holding PROQR THRAPEUTICS N V in Q1 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q3 2023$22,646
-19.8%
17,4200.0%0.00%
Q2 2023$28,221
+17.8%
17,420
+54.9%
0.00%
Q1 2023$23,958
-53.0%
11,248
+77.7%
0.00%
Q4 2021$51,000
-44.0%
6,330
-53.0%
0.00%
Q2 2021$91,000
-22.9%
13,481
-24.7%
0.00%
Q1 2021$118,000
-47.1%
17,913
-53.8%
0.00%
Q3 2019$223,000
-36.8%
38,7420.0%0.00%
Q2 2019$353,000
-26.0%
38,742
+12.6%
0.00%
Q1 2019$477,000
-28.4%
34,397
-18.5%
0.00%
Q4 2018$666,00042,1970.00%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q1 2023
NameSharesValueWeighting ↓
M28 Capital Management LP 1,910,600$2,483,7802.85%
Privium Fund Management B.V. 5,344,446$6,947,7802.07%
DAFNA Capital Management LLC 940,582$1,222,7570.38%
Monaco Asset Management SAM 377,517$490,7720.15%
EcoR1 Capital, LLC 2,980,016$3,874,0210.13%
Ikarian Capital, LLC 472,625$614,4120.07%
FRANKLIN STREET ADVISORS INC /NC 150,000$1950.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 3,625,467$4,713,1070.01%
GSA CAPITAL PARTNERS LLP 74,084$960.01%
UBS OCONNOR LLC 189,328$246,1260.01%
View complete list of PROQR THRAPEUTICS N V shareholders